EDUCATIONUniversity of Florida,Gainesville,FloridaPhDGraduate Student,Department of Pharmaceutical Outcomes & PolicyGraduated inAug. 2020University of Florida,Gainesville,FloridaMPHStudent,Department ofBiostatisticsGraduated inAug. 2019Long Island University, Brooklyn, New YorkMaster of Science in Drug Regulatory AffairsGraduated inMay. 2014King SaudUniversity, College of Pharmacy,Riyadh,Saudi ArabiaBachelor of Science in PharmacyGraduated in Jul.2007WORK EXPERIENCEAssistantProfessorNajran University, College of Pharmacy, Clinical Pharmacy PracticeDepartment,Najran, KSADec.2020-present•Developed& maintaineddocuments pertaining to the courses, includingassignments, syllabi and coursematerials•Evaluating student assignment results•Helped undergraduate pharmacy students in completing assignmentsTeaching AssistantNajran University, College of Pharmacy, Clinical Pharmacy Practice Department, Najran, KSAJan.2016-Dec.2020•Developed & maintained documents pertaining to the courses, including assignments, syllabi and coursematerials•Assistedfaculty in evaluating student assignment results•Helped undergraduate pharmacy students in completing assignmentsLecturerNajran University, College of Pharmacy, Clinical Pharmacy Practice Department, Najran, KSAAug.2009-Jan.2016•Developed & maintained documents pertaining to the courses, including assignments, syllabi and coursematerials•Assisted faculty in office duties such as copying, faxing and organizing student data•Assisted faculty in evaluating student assignment results•Helped undergraduate pharmacy students in completing assignmentsDrug InformationPharmacistSaudi Food and Drug Authority (SFDA), National Drug and Poisoning Information Center(NDPIC), Riyadh, KSAAug.2008-Aug.2009•Responded to drug information requests from the public,policy makers and healthcare professionals•Createdreports about safety and efficacy issues and reports for several pharmacy and therapeutic committees•Participated in developing and maintaining the Saudi National Formulary (SNF)•Participated in the development of national drug policies, public health education, awareness programs andclinical trials protocol evaluation•Remained current on topics of drug safety and effectiveness worldwide•Became familiar with a wide array of Medical Information Database resources•Appointed tothe Committee for theIdentification and Classification of Over-the-Counter Drugs (OTC) inSaudi Arabia•Participated intranslating varioustypes of medical information,includingarticles and news

Staff PharmacistSecurity ForcesHospital, Riyadh, KSAJul. 2007-Jul.2008•Consulted with patients on drug dosage, side effects and drugs interactions•ManagedElectronic prescription andaddressed related concerns•Communicatedwith medical staff and patients•Served on a rotational basis inOut-patient, In-patient, Primary Care, and Emergency pharmacies•Managed inpatient prescription including antibiotics, antineoplastic medication, IV fluids and TPNGraduate Trainee PharmacistKingdomHospital, Riyadh, KSAFeb.2007-May.2007•Graduate trained at all pharmacy departments including: Inpatient, Outpatient, Satellite,andEmergencyHONORS/AWARDS•Recipient, a research grant via the fast track to support COVID19 research from the King Abdulaziz City forScience and Technology in cooperation with the Ministry of Health (amount 410,432 Saudi riyals) as a co-investigator(2020)•Recipient, Rho Chi Honor, Arnold & Marie Schwartz College of Pharmacy and Health Sciences(2014)CERTIFICATIONS/TRAININGCOURSESClinical Safety & Pharmacovigilance, Drug Information Association (DIA)Aug.2013-Mar.2014Statistics in Medicine,Stanford University(onlinelearning), with distinctionJun.11, 2013-Aug.18, 2013From Bench to Bedside: Research Training Course,JohnsHopkins Hospital, Baltimore, MDJun.18-24, 2013Introduction to Regulatory Affairs Workshop by Catalent and MPCC, Alkhobar, KSA.Oct.18-22, 2008PROFESSIONALAFFILIATIONS/MEMBERSHIPSInternational Society For Pharmacoeconomics and Outcomes Research(ISPOR)2015-up to presentRho Chi (Pharmacy Honor Society)2013-up to presentDrug Information Association (DIA)2013-up to presentRegulatory Affairs Professionals Society (RAPS)2013-up to presentInternational Society of Pharmacovigilance (ISoP)2013-up to presentInternational Society for Pharmacoepidemiology (ISPE)2012-up to presentAmerican Association of Pharmaceutical Scientists(AAPS)2013-up to presentRegister pharmacist in Saudi Commission for Health Specialties2009-up to presentCOMMETTEES JOINEDOver-the-Counter (OTC) medicines Committee, Saudi Foodand Drug Authority2008-2010AssistantHead of the Central Unit for Academic Advising at Najran University January 2021-up to presentMemberofthe committee for developing the nationalguidelines for LTBI in Saudi Arabia July2021-up to presentMemberof the Central Unit forExaminingAcademicPerformanceat Najran UniversityAugust2021-up to presentACTIVITIESGraduateStudentRepresentatives, Dept.of Pharmaceutical Outcomes & Policy, University of Florida2017-2018JournalClubFacilitator, Dept.of Pharmaceutical Outcomes & Policy, University of Florida.2017-2018President,Association of Saudi Arabian Students at University of Florida,Gainesville, FL2017-2018Member,Saudi Students Club in Long Island University, Brooklyn, NY2013-2014Member,Saudi Students House in Pittsburgh, PA2011-2012Member,Students Committee at the College of Pharmacy in King Saud University2002-2007

SKILLSCOMPUTER:Word, PowerPoint, Excel,SAS (Statistical Analysis System)andSPSS (Statistical Package for theSocial Sciences)LANGUAGES(spoken & written):English &ArabicBasic Life Support Provider, Prince Salman Hospital, Riyadh, KSASep.13, 2009PUBLICATIONS1.Diaby V,Alqhtani H, van Boemmel-WegmannS, et al. A cost-effectiveness analysis of trastuzumab-containingtreatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan. The Breast. 2020;49:141-148.2.Diaby V, Wang C-Y,Alqhtani H, et al. Dataset used in the economic evaluation trastuzumab-based regimens forHER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting. Data in Brief.2020;29:105194.3.Okere AN, Sanogo V,Alqhtani H, DiabyV. Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machinelearning approach. Expert Rev Pharmacoecon Outcomes Res. 2020 Nov 11:1-6. doi:10.1080/14737167.2021.1842200. Epub ahead of print. PMID: 33131344.4.Hussain I, Yousaf N, Haider S, Jalil P, Saleem MU, Imran I, Majeed A, Rehman AU, Uzair M, Rasool MF,Alqahtani F,Alqhtani H. Assessing Knowledge and Perception Regarding Antimicrobial Stewardship andAntimicrobial Resistance in University Students of Pakistan: Findings and Implications. Antibiotics (Basel). 2021Jul 16;10(7):866. doi: 10.3390/antibiotics10070866. PMID: 34356787; PMCID: PMC8300619.5.Rasool, M.F.; Akhtar, S.; Hussain, I.; Majeed, A.; Imran, I.; Saeed, H.; Akbar, M.; Chaudhry, M.O.; Rehman,A.u.; Ashraf, W.; Alqahtani, F.;Alqhtani, H. A Cross-Sectional Study to Assess the Frequency and Risk FactorsAssociated with Cesarean Section in Southern Punjab, Pakistan. Int. J. Environ. Res. Public Health 2021, 18, 8812.https://doi.org/10.3390/ijerph18168812.CONFERENCES/SYMPOSIUMSRisk Management and Safety Communications Strategies,DrugInformation Association(DIA), Horsham, PANov. 4-5, 2013Safety and Social Media: Is this The Question or The Answer? Webinar,DrugInformation Association (DIA),Sep.12, 2013Pragmatic Approaches to Drug Safety Across the Pre-marketing and Post-marketing Continuum,DrugInformationAssociation (DIA), Boston,MAAug.12-14, 2013The 8th International Saudi Pharmaceutical Conference, Riyadh, kSAApr. 25-28, 2010Advanced Pharmacy Practice, Najran, KSA.May.18-19, 2010The 1st International Cardiovascular Pharmacotherapy Conference, Prince Sultan Cardiac Center, Riyadh, kSAJan.12-13, 2010The National Pharmacovigilance Center Launching Symposium, Saudi Food and Drug Authority, Riyadh, kSAMar.30-31, 2009The 3rd Pharmacist Day Symposium, Security Forces Hospital, Riyadh, kSAJan. 14, 2009The Hospital Disaster Management Symposium, Security Forces Hospital, Riyadh, kSAJun. 25, 2008The 7th International Saudi Pharmaceutical Conference, Riyadh, kSAMar.19-21, 2007